HOME >> BIOLOGY >> NEWS
Epigenetic activity silences Rb2/P130 gene in lung cancer

The attaching of methyl--or chemical--groups onto DNA sequences within the tumor suppressing gene Rb2/p130 can cause the gene to cease functioning in non-small lung cancer cells (NSLC) and retinoblastoma cells, researchers at Temple University's Sbarro Institute for Cancer Research and Molecular Medicine and Italy's University of Siena have discovered.

Their findings are reported in two studies: "Tumor-specific exon 1 mutations could be the 'hit event' predisposing Rb2/p130 gene to epigenetic silencing in lung cancer" and "Genetic and epigenetic alterations of RB2/p130 tumor suppressor gene in human sporadic retinoblastoma: implications for pathogenesis and therapeutic approach," both of which appear in September issues of Oncogene (http://www.nature.com/onc).

The joint studies at Temple and Siena were coordinated by Antonio Giordano, M.D., Ph.D., director of Sbarro Institute at Temple (http://www.shro.org), and by Marcella Macaluso of the Sbarro Institute and Caterina Cinti of both Centro Nazionale Ricerche and the University of Siena.

Giordano said that the researchers were puzzled when they found Rb2/130, the tumor suppressing gene discovered by Giordano in the early 1990s, in an epigenetic state in both the NSLC and retinoblastoma cells. In this epigenetic state, the gene showed no signs of mutation, but is silent in its expression or function.

Further examination of the gene found that it had been methylated, a process in which methyl or chemical groups attached themselves to the gene, attacking a sequence of the Rb2/p130's DNA and thus causing it to cease functioning.

"These studies are providing very important information on how cancerous and pre-cancerous conditions can be detected by the presence of the methylated state of Rb2/p130," said Giordano. "These cancerous or pre-cancerous conditions can be treated with drugs or agents that de-methylate the R
'"/>

Contact: Preston M. Moretz
pmoretz@temple.edu
215-204-7476
Temple University
12-Sep-2005


Page: 1 2

Related biology news :

1. Epigenetic studies will provide a better understanding of disease
2. Epigenetics to shape stem cell future
3. Epigenetic drugs, promising for breast cancer treatment
4. New view of cancer: Epigenetic changes come before mutations
5. Prenatal alcohol exposure alters brain activity in the frontal-striatal areas
6. Genes activity points to more lethal subtype of AML
7. Weizmann Institute scientists develop a general control switch for protein activity
8. Slow wave activity during sleep is lower in African-Americans than Caucasians
9. ChemGenex announces publication confirming activity of Ceflatonin in T315I-Positive CML
10. Neuronal activity gives clues to working memory
11. CSHL links activity in brain synapses and developmental abnormalities with schizophrenia gene

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/30/2020)... ... 2020 , ... Ever a responsive and supportive partner to ... critical information to life science organizations as they navigate the ever-changing economic and ... the most up-to-date actionable guidance and information has been a keystone of our ...
(Date:4/28/2020)... ... April 27, 2020 , ... Ofee.com, ... started by three teenagers with an idea to help millions of people during ... time of great need and suffering, an outlet has been created for people ...
(Date:4/26/2020)... ... 2020 , ... A team of researchers at the Icahn School of Medicine ... the virus that causes coronavirus disease (COVID-19). This antibody is intended to block the ... COVID-19. , The efforts are being led by Mone Zaidi, MD, PhD, MACP, Director ...
Breaking Biology News(10 mins):
(Date:5/15/2020)... ... 2020 , ... This new service offers clients a way to speak with ... as the need arises. Lachman’s OnCall SMEs have extensive knowledge of a wide range ... Lachman OnCall™ SMEs are available normal business hours Monday through Friday from 9:00 am ...
(Date:5/14/2020)... ... May 13, 2020 , ... Early stages of ... little or no information on the drug’s mechanism of action (MOA). Gene expression ... by measuring the activity of molecular pathways. This information can complement phenotypic readouts ...
(Date:5/1/2020)... , ... April 30, 2020 , ... ... announced today, honoring the businesses, policies, projects, and concepts that are actively engaged ... bioprinter for living cells, which has taken out the top prize in the ...
(Date:4/22/2020)... ... April 21, 2020 , ... ... through COVID-19. Many clinical trial teams are working remotely and have paused patient ... to help researchers continue their research during this uncertain time by giving research ...
Breaking Biology Technology:
Cached News: